Innovation Pharmaceuticals Inc (IPIX)

[djs7]

I have looked at Celgene's Otezla's phase 3 of 844 patients with 76 sites and compared it's completion time with Prurisol's phase 2B with 25 sites and 189 patients. Looks like Otezla Phase 3 maybe did 11.78 patients per week and probably 15 months to complete.

To do this rate patients per week rate with 189 patients (like Cellceutix has for 2B) would take about 17 sites. Cellceutix has 25 sites running with their Prurisol 2B.

The Prurisol 2B trial should be finished enrolling no later than March 31.
In other words, anytime now. IMHO

We are encroaching on week 18, about 4 1/2 months. Nothing is perfect in my estimate to grant this true, as all factors were not considered. However, the # of exclusion criteria are just about the same for Celgene Otezla trial and Cellceutix Prurisol 2B and Cellceutix is using 7 more sites to recruit what would take doing 189 patients (17 sites) for the Otezla Phase 3.

One holdup with recruiting may have come during Thanksgiving week and the Christmas holiday weeks (Dec 22 - Jan 2).

It's whenever as in it will happen soon.